Intensity Therapeutics, Inc. (INTS)
0.40
-0.01
(-2.03%)
USD |
NASDAQ |
Jan 20, 16:00
0.3988
0.00 (0.00%)
After-Hours: 20:00
Intensity Therapeutics EPS Diluted (Quarterly): -0.062 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Harvard Bioscience, Inc. | -0.0276 |
| Moleculin Biotech, Inc. | -17.02 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.671M |
| Total Expenses (Quarterly) | 2.671M |
| Enterprise Value | 17.58M |
| Earnings Yield | -158.6% |
| Normalized Earnings Yield | -158.67 |